465 related articles for article (PubMed ID: 5140093)
1. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
2. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
3. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
4. [Therapy of extrapyramidal-motor symptoms. Drug treatment].
Hartmann-von Monakow K
Bibl Psychiatr Neurol; 1969; 139():697-704. PubMed ID: 5406928
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
Rosati G; Agnetti V; Mura F; Granieri E
Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
[No Abstract] [Full Text] [Related]
6. [Long-term effects of amantadine in striatal syndromes].
Rovetta P
Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
[No Abstract] [Full Text] [Related]
7. [The treatment of parkinsonism with amantadine].
Völler GW
Dtsch Med Wochenschr; 1970 Apr; 95(17):934-7. PubMed ID: 5439551
[No Abstract] [Full Text] [Related]
8. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
9. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
Parkes JD; Baxter RC; Marsden CD; Rees JE
J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
[TBL] [Abstract][Full Text] [Related]
10. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
Kadykov AS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
[TBL] [Abstract][Full Text] [Related]
11. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
12. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
Man'kovskii NB; Vainshtok AB; Oleinik LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
[No Abstract] [Full Text] [Related]
13. Levodopa and amantadine in the treatment of Parkinsonism.
Critchley E
Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
[No Abstract] [Full Text] [Related]
14. A year's experience of L-DOPA in the treatment of Parkinson's disease.
Guidetti B; Giuffrè R
Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
[No Abstract] [Full Text] [Related]
15. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
16. [Parkinsonism].
Kaumeier S
Fortschr Med; 1978 Jul; 96(28):1397-404. PubMed ID: 27434
[No Abstract] [Full Text] [Related]
17. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
[No Abstract] [Full Text] [Related]
18. Treatment of parkinsonism with levodopa.
Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
[No Abstract] [Full Text] [Related]
19. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
20. [Conservative therapy in the Parkinson syndrome].
Birkmayer W
Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
